Background and Aims: Ultrasound [US] indices for assessing disease activity in IBD patients have never been critically reviewed. We aimed to systematically review the quality and reliability of available ultrasound [US] indices compared with reference standards for grading disease activity in IBD patients. Methods: Pubmed, Embase and Medline were searched for relevant literature published within the period 1990 to June 2017. Relevant publications were identified through full text review after initial screening by two investigators. Data on methodology and index characteristics were collected. Study quality was assessed using a modified version of the Quadas-2 tool for risk of bias assessment. Results: Of 20 studies with an US index, 11 studies met the inclusion criteria. Out of these 11 studies, 7 and 4 studied Crohn's disease [CD] and ulcerative colitis [UC0 activity indices, respectively. Parameters that were used in these indices included bowel wall thickness [BWT], Doppler signal [DS], wall layer stratification [WLS], compressibility, peristalsis, haustrations, fatty wrapping, contrast enhancement [CE], and strain pattern. Study quality was graded high in 5 studies, moderate in 3 studies and low in 3 studies. Ileocolonoscopy was used as the reference standard in 9 studies. In 1 study a combined index of ileocolonoscopy and barium contrast radiography and in 1 study histology was used as the reference standard. Only 5 studies used an established endoscopic index for comparison with US. Conclusions: Several US indices for assessing disease activity in IBD are available; however, the methodology for development was suboptimal in most studies. For the development of future indices, stringent methodological design is required.
Introduction
Assessing disease activity in inflammatory bowel disease [IBD] patients is becoming increasingly important. Treatment targets in IBD patients are shifting from symptom control to intestinal repair, an end point that has been associated with improved long-term outcomes. 1, 2 Ileocolonoscopy is the gold standard for the assessment of disease activity in IBD patients. Therefore, it is increasingly being implemented to guide treatment decisions and to evaluate treatment outcomes in clinical trials. Several endoscopic activity scores have been developed and validated and can be used to assess endoscopic disease activity. [3] [4] [5] [6] [7] [8] For optimal monitoring of disease activity in IBD patients, ileocolonoscopy should be performed on a regular basis. However, repeated colonoscopies represent a logistic and economic challenge, as well as significant burden for the patient. Moreover, there is a small risk of bowel perforation and transmural or extra-luminal disease activity, and complications such as abscesses cannot be assessed. Finally, the ileum cannot be intubated in a significant proportion of patients due technical or anatomical difficulties.
Biomarkers such as serum C-reactive protein [CRP] and fecal calprotectin have limited reliability for assessing and grading IBD disease activity. 9 Therefore, cross-sectional imaging modalities, such as trans-abdominal ultrasound [US], computed tomography [CT] and magnetic resonance imaging [MRI] are increasingly being used in the management of IBD. [10] [11] [12] These imaging techniques can be used to determine the extent and location of inflammation and to detect disease complication, such as stenosis, fistulas and abscesses in patients with Crohn's disease [CD] . 2, 10, 11, [13] [14] [15] [16] [17] [18] [19] [20] Magnetic resonance imaging and CT show good results for grading disease activity, but they are not ideal for repeated use due to logistical reasons [MRI] or radiation exposure [CT] . 10, 11 Since US is rapid, non-invasive, relatively cheap, and can even be performed in a point-of-care setting, it appears to be the most suitable modality for systematic monitoring in IBD patients. 21 An accurate US index for grading disease activity would therefore be of great clinical value. Although various US activity indices for IBD patients exist, and have also been evaluated in previous reviews, the applicability of US in grading disease activity remains uncertain. 11, 19, 22, 23 Also, a comprehensive evaluation of the characteristics and methods of all available studies focusing on US activity indices for assessing disease activity in IBD has never been conducted.
Here, we aim to critically review the quality and reliability of available US activity indices compared with reference standards for grading disease activity in IBD patients. This could serve as a basis for improving US activity indices and for the development of novel scoring systems.
Methods
This systematic review has been conducted in accordance with the Preferred Items for Systematic Reviews and Meta-analyses [PRISMA] guidelines. 24 The protocol has not been published in advance.
Literature search
PUBMED, MEDLINE, CENTRAL, and EMBASE were electronically searched for literature published within the period January 1990 until March 2017 on studies examining the use of US for grading disease activity in CD and UC. Details of the search criteria are provided in the supplementary material [Appendix E1]. All reference lists of the included studies were searched for potentially relevant records. KN] for eligibility for full text review. Subsequently, the selected full texts were assessed by both observers in order to identify studies with US indices. Finally, the remaining studies were assessed for inclusion by both observers. Disagreements were resolved through discussion after every phase in the selection process.
Inclusion and exclusion criteria

Data collection and analysis
The following data were collected on study characteristics: study design, diagnosis, number of included patients, number of US exams, segments analysed, patient selection and inclusion methods, reference test and index used, blinding methods, and time between reference and US exams. Additionally, the following data were collected on the US indices: index parameters, severity grades, cut-offs, index calculation methods, sensitivity, specificity, positive predictive value [PPV], negative predictive value [NPV], accuracy and correlation coefficients with reference test. A meta-analysis was not performed due the heterogeneity in study methodology and index characteristics.
Study quality grading
All included studies were graded for methodological quality by two investigators [SB and KN] with a modified version of the QUADAS-2 tool. 26 The QUADAS-2 tool is designed to assess the quality of diagnostic accuracy studies with signaling questions in 4 domains [patient selection, index test, reference test, and patient flow]. The signaling questions of the modified tool are shown in Table 1 . Established reference indices were considered as good quality reference standards. If existing reference indices were modified for the purpose of the study, they were considered as lower quality reference standards. The questions in each domain could be answered with 'yes', 'no', or 'unclear'. Unclear answers were considered as 'no' for the final quality grading. Each subdomain was graded as high risk of bias if ≥50% of the signaling questions were answered with 'no'. A study was graded as high quality in the case of a low risk of bias in at least 6 out of the 7 subdomains. A study was graded as low quality in the case of a high risk of bias in 4 or more subdomains. All other studies were graded as moderate quality. Any disagreements were resolved through discussion.
Results
Study selection
A total of 2103 records were identified through electronic search, and 1656 remained after removal of duplicates. One additional record was identified through other sources. This particular study was published after the search date, but we decided to include it due to its relevance. 27 After screening titles and abstracts, 140 potentially eligible studies were selected for full text review. After full text review, 20 records were identified that studied an US activity index [supplementary table 1]. Out of these 20 studies, 11 met the inclusion criteria. A chart flow of the selection process is shown in Figure 1 
Study characteristics
The study characteristics are shown in Table 2 . Eight studies used a prospective and two studies a retrospective design. One study consisted of a retrospective development phase and a prospective validation phase. The total number of studied subjects was 771 [mean 70.1; SD 56.2], and a total of 1088 [mean 98.9; SD 93.9] US exams were performed. In 4 studies, only the ileum was investigated. Ileocolonoscopy was used as the reference standard in 9 studies, in 1 study a combined index of ileocolonoscopy or barium contrast radiography was used as the reference standard, and in 1 study histology was used as the reference standard. Table 3 .
Crohn's disease ultrasonographic activity indices
Futagami et al. developed an US index with BWT and WLS as parameters. 28 The thresholds of the index were defined before the study. They compared the index with either endoscopy or barium contrast radiography in 55 patients. An endoscopic/radiological index was developed for comparison; thus, not all patients received the same reference standard. The overall correlation with the reference index was average [r 2 = 0.62; p < 0.01]. Neye et al. developed an US index with BWT and DS as parameters. 29 The thresholds of the index were defined before the study. The index was compared with a newly developed endoscopic activity index in 22 patients Drews et al. conducted a retrospective study comparing the Limberg score with histologic inflammation in ileum biopsies obtained by ileocolonoscopy in 32 CD patients. 30 This index was first proposed by Limberg and semiquantitatively measures DS in thickened bowel segments [>4 mm]. 31 A histologic index for severity of inflammation was developed for the study. The association between the Limberg score and histologic grades of disease activity was poor [κ = 0.4375].
Sasaki et al. conducted a retrospective study comparing the Limberg score with the SES-CD score in 108 CD patients. 32 Only the ileum was investigated. The correlation between US and endoscopy was good [Þ = 0.709; p < 0.001].
Paredes et al. developed an US index with BWT and DS for grading of post-surgical recurrence in 33 patients. 33 The index was compared with the endoscopic Rutgeerts score for post-operative recurrence in 33 patients. 34 The Rutgeerts score is a prognostic score to predict post-operative disease course. The thresholds of the US index were determined before the study. The correlation of the US index with the Rutgeerts score was poor [κ = 0.29; p = unknown]. For the diagnosis of moderate-severe recurrence, the correlation with endoscopy was average [κ = 0.57; p = 0.009]. A follow-up study with similar methods was conducted, combining the index with contrast enhanced ultrasound [CEUS] . 35 Postoperative recurrence was assessed in 60 CD patients. A cut-off of 34.5% of maximum contrast enhancement predicted endoscopic recurrence most accurately. In combination with the other US parameters, the accuracy was 94.4% and the correlation was good [κ = 0.82; p < 0.001]. A cut-off >46% contrast enhancement was best for the prediction of moderate-severe endoscopic recurrence. Pascu et al. developed an index with BWT, DS, compressibility, WLS and fatty wrapping as parameters. 36 The index was compared with ileocolonoscopy using a modified Baron score in 37 CD patients. 6 The thresholds of the index were defined before the study. The overall activity index was calculated by the sum of segmental indices. The overall correlation between US and ileocolonoscopy was good [r = 0.830; p < 0.001].
Novak et al. developed an index with BWT and DS as parameters. The study consisted of a retrospective phase for developing the index and a prospective phase for validating the index. The SES-CD or Rutgeerts score was used as the reference standard. The index was developed using univariate and multivariate logistic regression models. Cut-offs for discriminating between inactive/mild endoscopic disease and moderate/severe endoscopic disease were determined from the area under the receiver operating characteristic curve [AUROC] . The SES-CD cut-off for active versus inactive disease was >5. Also, there were 7 UC patients in the development cohort. Additionally, there were 63 patients and 87 examinations in the validation cohort; thus, for 24 patients 2 US examinations were used for the statistical calculations. In both phases, ultrasonographers and endoscopists were not blinded for the results of the other examinations. The final US score could be calculated using a formula [ Table 3 ]. The AUROC was 0.836 for discerning disease activity in the validation cohort. 
Ulcerative colitis ultrasonographic activity indices
Four US indices were identified. The parameters used in the indices included BWT, DS, WLS, compressibility, fatty wrapping, and strain pattern. Ulcerative colitis index details are provided in Table 4 .
Parente et al. developed an US index with BWT and DS for the assessment of mucosal healing. 2, 20 The index was compared with the endoscopic Baron score in 83 UC patients. 6 The thresholds of the US index were defined before the study. Patients were assessed at 0, 3, 9, and 15 months. At baseline, all patients had US scores and baron scores of 2-3. Concordance of the severity classes was average, with a weighted κ coefficient of 0. Pascu et al. developed an US index with BWT, DS, compressibility, WLS, and fatty wrapping as parameters. 36 The index was compared with a modified Baron score in 24 UC patients. The US activity index showed a strong correlation with ileocolonoscopy [r = 0.974, p < 0.001].
Grading of study quality
Study quality was graded high in five studies, moderate in three studies, and low in three studies. Most concerns were raised in the subdomains regarding the index test and the reference standard. Blinding was performed properly in most studies, but in nine studies the thresholds of the index were defined before the study was performed. Civitelli et al. developed the US index using the reference standard as a dependent variable. Novak et al. developed the index in a retrospective study and validated it in a prospective study. Both studies were therefore used for quality grading. Five studies used an established endoscopic reference index [i.e. SES-CD, Mayo, Rutgeerts score]. In the other studies, either a newly developed index or a modified Baron index was used. Methods for patient selection were suboptimal in three studies. Flow and timing were good in all studies. The results of the Quadas-2 assessment are shown in Table 5 . There were no studies that used central reading or inter-and intra-observer variability assessment, and only the study performed by Novak et al. used a development and validation phase.
Discussion
To our knowledge, this is the first comprehensive systematic review on US scoring indices that can be used to assess disease activity in IBD patients. The methods that were used for the development of these indices were suboptimal in most studies. Although 20 studies were identified that studied an US activity index, 9 were excluded due to small patient numbers or because clinical activity indices were used as the reference standard, indicating poor methodology. Out of 11 included studies, only 5 of them were graded as high quality using the modified Quadas-2 tool. Based on these findings, we conclude that the methodology for the development of US indices for grading disease activity in IBD patients should be improved in future studies.
Important criteria for the development of a diagnostic index are appropriate patient selection, a proper sample size, implementation of blinding, use of an established reference index, inclusion of patients with different disease activity, and proper study flow and timing [i.e. time between index and reference test and comparison of all patients with the same reference standard]. 26 In addition, a diagnostic index should ideally be developed using the reference index as the dependent variable. Parameters of the imaging modality that can predict outcomes of the reference index should be determined and used for further development of the index. Subsequently, the most predictive cut-off values should be determined with appropriate statistical methods. 39 The methods that were used for the development of the so-called simple endoscopic indices for CD [CDEIS and SES-CD] are good examples of such an approach. 3, 8 The most commonly used parameters in both the CD and UC indices were BWT, DS, and WLS [10, 9, and 3 indices in CD and 3, 3, and 2 indices in UC, respectively]. Bowel wall thickness is the only quantifiable measurement, and in theory is probably the easiest to reproduce. However, it is important to standardize measurement methods in order to get reproducible results [i.e. measurement location and probe handling]. DS is usually measured semi-quantitatively and thus is more prone to interpretation. Additionally, the amount of DS is influenced by equipment and patient characteristics such as the amount of body fat and location of inflammation. To optimize reproducibility, clear definitions should be used and settings on the US scanner should be optimized and remain constant when assessing different patients [i.e. slow-flow settings]. The assessment of WLS is also more subjective and thus clear definitions should be used. Fatty wrapping [FW] , haustrations, compressibility, and peristalsis were rarely used as index parameters. However, FW is considered as an important finding and should be considered for score development in the future, especially in CD patients.
Ileocolonoscopy was used as the reference standard in most of the included studies [n = 9], but only five studies compared US with an established endoscopic index [i.e. SES-CD, Mayo, Rutgeerts' score]. In the other four studies, a newly developed or a modified index was used as the reference standard. Pascu et al. used, for example, the modified Baron score for assessing disease activity in both CD and UC. Since CD and UC are different entities, activity cannot be scored with the same scoring system. Futugami et al. used an activity score that was based on both endoscopic and barium contrast radiography findings in CD patients. It is likely that the comparison with these non-established reference indices has biased the results in these studies. This is also reflected by the wide range in statistical association between US and endoscopic indices in these studies.
Additionally, in all these studies, the thresholds for ultrasonographic parameters were determined before the study. Establishment of index thresholds prior to a study is likely to result in overestimation of the diagnostic value. 39 Civitelli et al. used an endoscopic index [Mayo endoscopic score] as a dependent variable in order to determine thresholds of US parameters for the development of an US index for paediatric UC patients. 38 Additionally, Novak et al. conducted a retrospective study in which they determined parameters, cut-off values, and the formula for calculating the activity score. 27 As a next step, they validated the index formula prospectively. However, a major limitation of this study was that ultrasonographers and endoscopists were not blinded for the results of the other examinations. Moreover, the SES-CD cut-off that was used for active disease was quite liberal [SES-CD >5], and there were 7 UC patients in the development cohort.
Drews et al. compared the Limberg score [see Table 3 for index characteristics] with histologic inflammation in biopsies in CD patients. Correlation between this score and the histology index was poor to average, depending on the cut-off values that were used. This could be explained by the fact that the location of, or small amount of tissue obtained through, biopsies may not accurately reflect disease activity. Additionally, a non-validated histology index was used. The Limberg score does seem to correlate better with endoscopic disease activity, as was shown by Sasaki et al. 32 However, the data for this study were collected retrospectively, which may have introduced bias. Additionally, only ileal disease was compared in these studies, since the Limberg score was initially developed to assess the ileum. Interestingly, we found no studies that used an alternate crosssectional imaging modality [e.g. MRI or CT] as the reference standard. This could be explained by the fact that disease activity indices for these modalities are also relatively rare, and that no standard and widely used activity index exists [i.e. such as the SES-CD or Mayo score]. A comprehensive systematic review by Puylaert et al. described 11 studies on MRI and 3 studies on CT for grading of disease activity, which all used endoscopy, biopsies, or surgical specimens as the reference standard. 11 This confirms our finding that thus far, US has not been compared with activity indices from other crosssectional modalities. Such comparisons could be of value and should be conducted in future studies.
Small intestine contrast ultrasonography has also been studied for the grading of disease activity in IBD. We identified two studies describing a SICUS activity index. 40, 41 However, both studies used clinical disease activity as the reference standard and therefore did not meet the inclusion criteria. Some studies have shown higher sensitivity and specificity of SICUS for the detection of inflammation than regular US. [42] [43] [44] The development of SICUS indices with use of a good reference standard could therefore be of important value. SICUS is, however, more time consuming than regular US and thus is probably less useful in a point-of-care setting.
The value of contrast enhancement for the assessment of disease activity in IBD is increasingly being studied. It seems to have promising potential for the assessment of disease activity. [45] [46] [47] For instance, the pattern of bowel wall enhancement and perfusion quantification may have value for disease activity assessment. 35, 46, [48] [49] [50] [51] The only index using CEUS that met our inclusion criteria was developed by Paredes et al. 35 They showed a high accuracy of CEUS for the assessment of postoperative recurrence in 33 patients. We identified one other index using CEUS. 52 However, this study was excluded because a clinical activity index was used as the reference standard. It is to be expected that CEUS will be increasingly used for the development of new indices in the future. However, it is important to note that CEUS parameters are more equipment dependent than classical US parameters. Additionally, results from perfusion quantification can currently not be compared between different ultrasound scanners. 53 It has also been postulated that CEUS could be useful for differentiating between fibrosis and inflammation. However, results from different studies regarding this topic are conflicting. 52, [54] [55] [56] Therefore, it remains to be seen if CEUS truly will have additional value for differentiation between disease activity and fibrosis. Finally, CEUS is more expensive and time-consuming than regular US.
We identified one index using real-time elastography for the assessment of disease activity in UC patients. 37 Although the concept seems interesting, many factors in this study may have introduced bias. For instance, endoscopic findings from specific locations were compared with US, but in reality it is difficult to compare precise locations between two modalities. The elastographic patterns also seemed difficult to interpret. This complicates the applicability and reproducibility of the index. Finally, no established endoscopic index was used as a reference standard. Elastography probably has more value for the detection of fibrotic intestinal tissue, as was shown in several studies. 57, 58 US for grading disease activity in IBD has been reviewed by other groups. Rimola et al. evaluated four US studies in a systematic review on different imaging modalities in CD patients. 23 They reported good accuracy of the different indices, but they did not assess the quality of these studies. Puylaert et al. reviewed several imaging modalities for the grading of disease activity in CD, but they included only two US studies. 11 They concluded that US has low accuracy for disease activity grading in CD, but the number of patients [n = 86] used in their analysis was relatively low. Panes et al. discussed 12 US studies for grading the disease severity of 1231 patients and concluded that US findings correlate well with endoscopy and histology, but not with clinical activity indices and biomarkers. 19 However, study and index quality were not assessed. Moreover, most studies that were reviewed used clinical and/or biochemical activity as a reference standard. Calabrese et al. recently reviewed a variety of aspects of US in CD, but only briefly elaborated on the use of US for grading CD activity. 22 They stated that the role of US in the evaluation of inflammatory activity remains controversial. Hence, the contradictory conclusions of these reviews exemplify the uncertainty regarding the use of US for disease activity grading in IBD and are probably caused by the heterogeneity of the different US activity indices that have been developed so far.
Our study has some limitations. First, we decided not to perform a meta-analysis. In our opinion, a meta-analysis could not be performed due to the considerable differences between the studies and would probably have resulted in highly biased results. Second, some factors that are important for the development of diagnostic indices (such as implementation of central reading, interobserver variability, and the conduction of a development and validation study) are not part of the Quadas-2 tool. However, there were no studies that used central reading or interobserver variability assessment, and only the study performed by Novak et al. used a development and validation phase.
In conclusion, gastrointestinal US seems a promising tool for the assessment of disease activity in IBD patients, but most available activity indices have been developed with suboptimal methodology. New indices should be developed with better methods in future studies. A reliable and standardized US activity index would be useful for facilitating the clinical decision-making process and for assessing and monitoring treatment outcomes in daily practice and in clinical trials.
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